Status:
UNKNOWN
Yoga Pranayama Adjuvant to Treat Burden COVID-19
Lead Sponsor:
Health Ricerca e Sviluppo S.R.L.
Collaborating Sponsors:
Swami Vivekananda Yoga Anusandhana Samsthana, Bangaluru , India
Yoga Experience Association,Cervia (Ra), Italy
Conditions:
Coronavirus Infection
Cytokine Storm
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
COronaVIrus Disease or Severe Acute Respiratory Syndrome -CoV-2 or COVID-19, mortality occurs mainly from immunological behavior or by suicide after healing . In both cases, the causal link is coronav...
Detailed Description
COronaVIrus Disease or Severe Acute Respiratory Syndrome -CoV-2 or COVID-19, pandemic threatens patients, societies and healthcare systems around the world. Morbidity and lethality have a direct link ...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the trial;
- Male or Female, aged 18 years or above;
- Diagnosed COVID-19's infection;
- Informed consent;
- Having been diagnosed in the last 1 week;
- In the Investigator's opinion, is able and willing to comply with all trial requirements;
- Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the trial;
- Patients who continue to be followed at home.
Exclusion
- The participant may not enter the trial if ANY of the following apply:
- No informed consent;
- Participant is not willing and able to give informed consent for participation in the trial;
- Female participant who is pregnant, lactating or planning pregnancy during the course of the trial;
- Hospitalization patients;
- Having a serious cognitive impairment;
- Having serious hearing and vision problems;
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial;
- Participants who have participated in another research trial involving an investigational product in the past 12 weeks.
Key Trial Info
Start Date :
August 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04413747
Start Date
August 15 2020
End Date
September 30 2021
Last Update
August 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ambulatorio Telemedicina Giardino St Lucia
Massa Lombarda, Ravenna, Italy, 48024